Aethron Labs

Building foundation models that transform scientific data into actionable discovery.

Get in Touch

What We Do

Aethron Labs is an independent research lab focused on developing large-scale machine learning systems for interpreting complex scientific data. Our work is centered on building foundational capabilities rather than narrow tools or application-specific models.

NexaMol Progress

What We've Built

Foundation & Data

  • Acquired ~201M spectrum (~500GB) mass spectrometry dataset
  • Built high-performance Rust + Python preprocessing pipeline
  • Achieved ~160,000 spectra/sec throughput on commodity CPUs
  • Processed ~70% of full dataset into verified, versioned shards

Model Architecture

  • Designed foundation model roadmap (V1–V3: 3B → 5B → 7B params)
  • Unified heterogeneous instrument data under single representation
  • Implemented strict train/test/validation splits to prevent leakage
  • Built Arrow-based optimized training shards and HDF5 workflows

Commercial Execution

  • Identified CROs as primary commercial customer segment
  • Conducted direct outreach to multiple CROs and industry contacts
  • Applied to fellowships, incubators, and funds (BoostVC, Convergent, Artizen)
  • Created realistic ignition → pre-seed execution plan

The Problem

Across the life sciences and molecular research, data generation has dramatically outpaced our ability to interpret it. Core analytical technologies produce enormous volumes of rich, high-dimensional measurements, yet downstream understanding still depends on fragile heuristics, limited reference data, and manual analysis.

This gap constrains discovery, slows research, and limits what can be reliably inferred from experimental data.

Our Approach

We believe this is fundamentally a representation problem. Aethron Labs is building foundation models that learn directly from raw scientific data, capturing underlying structure in a way that generalizes across instruments, conditions, and experimental settings.

The goal is not to replace existing workflows, but to create a new computational substrate that makes scientific interpretation more scalable, reliable, and extensible.

Market Opportunity

Note: Aethron Labs is currently in the development phase. The market projections below are based on preliminary market research and industry analysis.

Top-down Context

$200B

Global pharmaceutical R&D spend annually

$90B

Global CRO market size annually

$50B+

Addressable analytical services market

This spend is recurring, operational, and directly tied to throughput and turnaround time.

Bottom-up Entry Wedge

Mid-to-large CROs typically operate 10s-100s of LC-MS/MS instruments processing millions of spectra per year, with teams of analysts whose time is the primary cost driver.

30-50%

Reduction in manual interpretation time

10-100+

Instruments per large CRO

1M+

Spectra analyzed annually

Initial commercialization targets enterprise API licensing for programmatic molecular search and analysis, priced against analyst time and throughput rather than per-sample novelty.

Near-term Serviceable Market

  • Targeting ~200-500 CROs and pharma analytical groups globally
  • Early adopters likely top 10-50 CROs by analytical volume
  • Initial contracts plausibly in the $100k-$1M ARR range per customer

This supports a credible $50-200M serviceable obtainable market before broader expansion.

Go-To-Market

Simple and Credible

The initial GTM is intentionally narrow and execution-driven.

Aethron Labs targets CROs first, not broad enterprise rollouts. CROs feel the MS/MS bottleneck most acutely: turnaround time, analyst throughput, and defensibility of results directly determine their margins and competitiveness.

The Approach:

  1. Direct CRO outreach to identify high-pain workflows (metabolite ID, impurity analysis, dereplication).
  2. Small, well-scoped pilots where the system runs alongside existing tools, measured on concrete metrics (time saved, coverage, analyst effort).
  3. API-level integration into existing pipelines - no UI disruption, no workflow replacement.
  4. Convert validated pilots into paid API access or enterprise licensing, with expansion driven by usage and downstream pharma pull-through.

This turns latent demand into evidence. The goal is not rapid scaling at first, but credible proof that this infrastructure works in real workflows.

What This Becomes

What begins as programmatic molecular search for LC-MS/MS expands as models and representations mature:

Phase 1 - Molecular Interpretation Infrastructure

  • LC-MS/MS annotation and search
  • Metabolomics and impurity identification
  • Direct integration into CRO and pharma pipelines

Phase 2 - Embedded Discovery Infrastructure

Used across drug discovery, DMPK, metabolomics, and materials research.

Becomes a standard interpretation layer rather than a standalone tool.

Phase 3 - Scientific Foundation Infrastructure

A reusable computational substrate for molecular science, materials science, and other data-intensive physical sciences.

TAM expands to multiple tens of billions across research, instrumentation, and discovery workflows.

At this stage, the opportunity expands from tooling budgets to core scientific computing infrastructure.

Founder Profile

Founder: Allan

5 years total experience in ML and scientific computing

3 years in open-source development and research:

  • Molecular science
  • Biomaterials
  • Quantum systems
  • Computational fluid dynamics

2 years industry experience:

  • Startups
  • Large-scale production and infrastructure environments

This background spans the full stack required for this problem: scientific domain understanding, large-scale ML systems, and production engineering realities.

Aethron Labs is structured to reflect this combination from day one.

Motivation

This effort is motivated by a rare convergence:

  • Scientific fields are generating orders of magnitude more data
  • Interpretation remains the bottleneck
  • Modern machine learning can now operate at the scale and complexity required

The opportunity is not incremental optimization. It is to define a new category of scientific infrastructure that sits between raw experimental data and downstream discovery.

By starting with a concrete, economically grounded use case (CRO workflows) and expanding deliberately, Aethron Labs aims to:

  • Accelerate scientific discovery
  • Improve reproducibility
  • Create durable infrastructure with impact beyond a single domain

This is a long-term bet on advancing science as a system, not just improving a workflow.

Contact

If you work in scientific research, analytical chemistry, pharma, or scientific machine learning, and are interested in exchanging perspectives, I welcome the conversation.

Get in Touch